Publications by authors named "Moshe J Inbar"

Claim this Profile
P
Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
Christoph Zielinski, Istvan Lang, Semir Beslija, Zsuzsanna Kahan, Moshe J Inbar

Br J Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial.
Tamar Safra, Rinat Bernstein-Molho, Julia Greenberg, Sharon Pelles-Avraham, Irina Stephansky, Moshe J Inbar

Oncology· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Tamar Safra, Joseph Menczer, Rinat Molho Bernstein, Shulem Shpigel, Dianna Matcejevsky, Moshe J Inbar

Gynecol Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complexity of management of pregnancy-associated malignant soft tissue and bone tumors.
Rinat Bernstein Molho, Yehuda Kollender, Josephine Issakov, Jacob Bickels, Gideon Flusser, Moshe J Inbar

Gynecol Obstet Invest· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer.
Tamar Safra, Joseph Menczer, Rinat Bernstein, Shulem Shpigel, Moshe J Inbar

Gynecol Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study.
Ilan G Ron, David Sarid, Larisa Ryvo, Einat Even Sapir, Shlomo Schneebaum, Moshe J Inbar

Melanoma Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year maintenance of carboplatin in patients with epithelial ovarian cancer--a phase II study.
Tamar Safra, Felix Kovner, Nelly Barak, Moshe J Inbar, Ilan G Ron

Isr Med Assoc J· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for spinal cord compression in patients with soft-tissue sarcoma.
Ofer Merimsky, Yehuda Kollender, Felix Bokstein, Josephine Issakov, Gideon Flusser, Moshe J Inbar

Int J Radiat Oncol Biol Phys· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Ilan G Ron, Nely Wigler, Riva Borovik, Tamar Peretz, Shulamith Rizel, Moshe J Inbar

Am J Clin Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis